维普中文期刊产品整合服务
21篇 您的检索式:作者名="Eric Watson"
    题名 作者 年代 出处 被引量
1甲醛固定石蜡包埋组织中DNA的降解情况显示文摘田子强 刘俊峰 王贵英 Eric Smith Paul Drew David Watson Glyn G Jamieson 2004中华病理学杂志2004,33,3:4
2Comparison Between Angiography and Fractional Flow Reserve Versus Single-Photon Emission Computed Tomographic Myocardial Perfusion Imaging for Determining Lesion Significance in Patients With Multivessel Coronary Disease显示文摘Michael Ragosta Andrew H. Bishop Lewis C. Lipson Denny D. Watson Lawrence W. Gimple Ian J. Sarembock Eric R. Powers 2007The American Journal of Cardiology2007,,7:2
3GLC - mass spectrometry of several important anticancer drugs I: Pertrimethylsilylation and' O - Me- thoxime formation显示文摘Eric Watson 1978Journal of Pharmaceutical Science1978,67,9:1
4Maternal and Fetal Outcome After Colectomy for Fulminant Ulcerative Colitis During Pregnancy: Case Series and Literature Review显示文摘Eric J. Dozois Bruce G. Wolff William J. Tremaine William J. Watson Ernesto R. Drelichman Peter W. G. Carne Julie L. Bakken 2005Diseases of the Colon & Rectum2005,,1:1
5Review of volatile organic compound source apportionment by chemical mass balance显示文摘John G. Watson Judith C. Chow Eric M. Fujita 2001Atmospheric Environment2001,,9:1
6The REMATCH trial: rationale, design, and end points显示文摘Eric A Rose Alan J Moskowitz Milton Packer Josephine A Sollano Deborah L Williams Anita R Tierney Daniel F Heitjan Paul Meier Deborah Davis Ascheim Ronald G Levitan Alan D Weinberg Lynne Warner Stevenson Peter A Shapiro Ronald M Lazar John T Watson Daniel 1999The Annals of Thoracic Surgery1999,,3:1
7Review of volatile organic compound source apportionment by chemical mass balance显示文摘John G. Watson Judith C. Chow Eric M. Fujita 2001Atmospheric Environment2001,,9:1
8Review of volatile organic compound source apportionment by chemical mass balance显示文摘John G. Watson Judith C. Chow Eric M. Fujita 2001Atmospheric Environment2001,,9:1
9Undetectable Preoperative Levels of Serum CA 19-9 Correlate with Improved Survival for Patients with Resectable Pancreatic Adenocarcinoma显示文摘Adam C. Berger MD Ingrid M. Meszoely MD Eric A. Ross PhD James C. Watson MD John P. Hoffman MD 2004Annals of Surgical Oncology2004,,7:1
10THE 4C APPROACH AS A WAY TO UNDERSTAND SPECIES INTERACTIONS DETERMINING INTERCROPPING PRODUCTIVITY显示文摘Modern agriculture needs to develop transition pathways toward agroecological,resilient and sustainable farming systems.One key pathway for such agroecological intensification is the diversification of cropping systems using intercropping and notably cereal-grain legume mixtures.Such mixtures or intercrops have the potential to increase and stabilize yields and improve cereal grain protein concentration in comparison to sole crops.Species mixtures are complex and the 4C approach is both a pedagogical and scientific way to represent the combination of four joint effects of Competition,Complementarity,Cooperation,and Compensation as processes or effects occurring simultaneously and dynamically between species over the whole cropping cycle.Competition is when plants have fairly similar requirements for abiotic resources in space and time,the result of all processes that occur when one species has a greater ability to use limiting resources(e.g.,nutrients,water,space,light)than others.Complementarity is when plants grown together have different requirements for abiotic resources in space,time or form.Cooperation is when the modification of the environment by one species is beneficial to the other(s).Compensation is when the failure of one species is compensated by the other(s)because they differ in their sensitivity to abiotic stress.The 4C approach allows to assess the performance of arable intercropping versus classical sole cropping through understanding the use of abiotic resources.Eric JUSTES Laurent BEDOUSSAC Christos DORDAS Ela FRAK Gaetan LOUARN Simon BOUDSOCQ Etienne-Pascal JOURNET Anastasios LITHOURGIDIS Chrysanthi PANKOU Chaochun ZHANG Georg CARLSSON Erik Steen JENSEN Christine WATSON Long LI 2021Frontiers of Agricultural Science and Engineering2021,8,3:1
11Review of volatile organic compound source apportionment by chemical mass balance显示文摘John G. Watson Judith C. Chow Eric M. Fujita 2001Atmospheric Environment2001,,9:1
12GLC-mass spectrometry of several important anticancer drugs I: Pertrimethylsilylation and O-Methoxime formatin 显示文摘Eric Watson 1978Journal of Pharmaceutical Science1978,67,9:1
13Review of volatile organic compound source apportionment by chemical mass balance显示文摘John G Watson Judith C Chow Eric M Fujita 2001Atmospheric Environment2001,35,:1
14The Metastatic/Examinod Lymph Node Ratio Is an Important Prognostic Factor After Pancreaticoduodeneetomy for Pancreatic Cancer 显示文摘Adam C Berger C Watson Eric A Ross 2004The American Surgeon2004,70,3:1
15Evalluation of filterbased aerosol measurements during the 1987 southern California air quality study 显示文摘Chow Judith C Eric MFujita Watson John G Lu Zhiqiang Lawson Dougas R Ashbaugh Lowel 1 1994Environmental Monitoring and Assessment1994,30,:1
16Undetectable Preoperative Levels of Serum CA 19-9 Correlate with Improved Survival for Patients with Resectable Pancreatic Adenocarcinoma显示文摘Adam C. Berger MD Ingrid M. Meszoely MD Eric A. Ross PhD James C. Watson MD John P. Hoffman MD 2004Annals of Surgical Oncology2004,,7:1
17Review of volatile organic compound source apportionment by chemical mass balance显示文摘John G. Watson Judith C. Chow Eric M. Fujita 2001Atmospheric Environment2001,,9:1
18Measurement of the Modeling Parameters for a Mali flex 'B' Springboard显示文摘Eric J S Denise S S Watson L G 1990INTERNATIONAL IOURNAL OF SPORT BIOMECHANICS1990,,6:1
19ENABLING CROP DIVERSIFICATION TO SUPPORT TRANSITIONS TOWARD MORE SUSTAINABLE EUROPEAN AGRIFOOD SYSTEMS显示文摘European cropping systems are often characterized by short rotations or even monocropping,leading to environmental issues such as soil degradation,water eutrophication,and air pollution including greenhouse gas emissions,that contribute to climate change and biodiversity loss.The use of diversification practices(i.e.,intercropping,multiple cropping including cover cropping and rotation extension),may help enhance agrobiodiversity and deliver ecosystem services while developing new value chains.Despite its benefits,crop diversification is hindered by various technical,organizational,and institutional barriers along value chains(input industries,farms,trading and processing industries,retailers,and consumers)and within sociotechnical systems(policy,research,education,regulation and advisory).Six EU-funded research projects have joined forces to boost crop diversification by creating the European Crop Diversification Cluster(CDC).This Cluster aggregates research,innovation,commercial and citizen-focused partnerships to identify and remove barriers across the agrifood system and thus enables the uptake of diversification measures by all European value-chain stakeholders.The CDC will produce a typology of barriers,develop tools to accompany actors in their transition,harmonize the use of multicriteria assessment indicators,prepare policy recommendations and pave the way for a long-term network on crop diversification.Antoine MESSEAN Loïc VIGUIER Lise PARESYS Jean-Noel AUBERTOT Stefano CANALI Pietro IANNETTA Eric JUSTES Alison KARLEY Beatrix KEILLOR Laura KEMPER Frédéric MUEL Barbara PANCINO Didier STILMANT Christine WATSON Helga WILLER Raul ZORNOZA 2021Frontiers of Agricultural Science and Engineering2021,8,3:0
20Longitudinal assessment of liver stiffness by transient elastography for chronic hepatitis C patients显示文摘BACKGROUND Liver fibrosis is a common pathway of liver injury and is a feature of most chronic liver diseases.Fibrosis progression varies markedly in patients with hepatitis C virus(HCV).Liver stiffness has been recommended as a parameter of fibrosis progression/regression in patients with HCV.AIM To investigate changes in liver stiffness measured by transient elastography(TE)in a large,racially diverse cohort of United States patients with chronic hepatitis C(CHC).METHODS We evaluated the differences in liver stiffness between patients treated with direct-acting antiviral(DAA)therapy and untreated patients.Patients had≥2 TE measurements and no prior DAA exposure.We used linear regression to measure the change in liver stiffness between first and last TE in response to treatment,controlling for age,sex,race,diabetes,smoking status,human immunodeficiency virus status,baseline alanine aminotransferase,and baseline liver stiffness.Separate regression models analyzed the change in liver stiffness as measured by kPa,stratified by cirrhosis status.RESULTS Of 813 patients,419(52%)initiated DAA treatment.Baseline liver stiffness was 12 kPa in 127(16%).Median time between first and last TE was 11.7 and 12.7 mo among treated and untreated patients,respectively.There was no significant change in liver stiffness observed over time in either the group initiating DAA treatment(0.016 kPa/month;CI:-0.051,0.084)or in the untreated group(0.001 kPa/mo;CI:-0.090,0.092),controlling for covariates.A higher baseline kPa score was independently associated with decreased liver stiffness.CONCLUSION DAA treatment was not associated with a differential change in liver stiffness over time in patients with CHC compared to untreated patients.Anya Mezina Arunkumar Krishnan Tinsay A Woreta Kevin B Rubenstein Eric Watson Po-Hung Chen Carla Rodriguez-Watson 2022World Journal of Clinical Cases2022,10,17:0
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费